SCHEMBL30770475

SCHEMBL30770475

CC(C)(O)c1cc(F)c([S@](N)(=O)=NC(=O)Nc2c3c(cc4c2CCC4)CCC3)s1

nearest known ligand 0.46

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
NLRP3 Q96P20 19/20 0.46
CA2 P00918 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30244236 1.00 NLRP3 (0.46) NLRP3CA2
SCHEMBL30243883 1.00 NLRP3 (0.46) NLRP3CA2
SCHEMBL20692309 1.00 NLRP3 (0.46) NLRP3CA2
SCHEMBL30244350 0.98 NLRP3 (0.45) NLRP3CA2
SCHEMBL22013534 0.98 NLRP3 (0.45) NLRP3CA2
SCHEMBL30244159 0.98 NLRP3 (0.45) NLRP3CA2
SCHEMBL20692431 0.98 NLRP3 (0.45) NLRP3CA2
SCHEMBL22013532 0.93 NLRP3 (0.41) NLRP3CA2
SCHEMBL30244096 0.93 NLRP3 (0.41) NLRP3CA2
SCHEMBL30244218 0.93 NLRP3 (0.41) NLRP3CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4349820-A2 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY Novartis AG (CH) 2024-04-10 EP disclosed
EP-3658539-B1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS AG (CH) 2024-02-21 EP disclosed
EP-3880659-B1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS AG (CH) 2024-01-03 EP disclosed